Fig 1. Disease site distribution by gender in the whole cohort and in the early mortality group.

Left Panel-525,780 Patients with de-novo metastatic cancer were analyzed by disease site origin, separated by gender. Right Panel -109,207 patients which died in the first two months after disease diagnosis analyzed by disease site origin, separated by gender. Primary site color code differs between genders and appears in the middle.